UPClytics
View all cases

UPC CoA 150/2025

Feb 18, 2025·EP2501384 · METHOD OF TREATING PROLIFERATIVE DISORDERS AND OTHER PATHOLOGICAL CONDITIONS MEDIATED BY BCR-ABL, C-KIT, DDR1, DDR2 OR PDGF-R KINASE ACTIVITY

Case details
Status
Case Closed
Action
Appeal
Category
File-access requests (R. 262.1(b))
Parties
Claimants
Representatives
  • Phillip Rektorschek
Respondents
Representatives
Division
Court of Appeal
Technology
  • Chemistry
    Organic fine chemistry · Pharmaceuticals
Language
English
First decided
Apr 14, 2025
EPO Opposition
  • Fresenius Kabi Deutschland GmbHAdmissible2016-11-14
  • Hamm&Wittkopp Patentanwälte PartmbBAdmissible2016-11-17
  • Teva Pharmaceutical Industries LtdAdmissible2016-11-17
  • Intas Pharmaceuticals Ltd.Admissible2016-11-17
  • Generics (U.K.) LimitedAdmissible2016-11-17
  • TEVA PHARMACEUTICAL INDUSTRIES, LTD.Admissible2016-11-17
How this compares
How long the court takes to reach a first decision.
Median days to first decision
All UPC124
Judge Rian KaldenLocked
Judge Patricia RombachLocked
Judge Ingeborg SimonssonLocked

At the UPC: STADAPHARM GmbH (10 cases)·Accord Group (8 cases)

This dispute contains 1 other proceedings

UPC APP 68658/2024

1 other defendants litigating the same or a related patent

UPC APP 9038/2025

Start a free trial to see how each one ended.

More cases: Court of Appeal·2025

Decisions
  • 2025-04-14
    Appeal RoP220.2Public

    Summary: The Court of Appeal reversed the first-instance order and granted Stadapharm access to the statement of claim and annexes filed by Accord in a now-withdrawn declaration of non-infringement action against Novartis, finding that following withdrawal of the main proceedings all parties consented and no confidentiality concerns remained apart from personal data redactions.

    Show the legal issues (4)
    • Public access to register (R.262.1(b) RoP)
    • Third-party access to pleadings
    • Specific interest in access
    • Withdrawal of main proceedings and effect on access
Documents
Document titleDatePublic
Outcome of the Order2025-04-15Not public
Final order2025-04-15Public
Headnote-and-Keywords2025-04-14Not public
Acknowledgement-of-lodging2025-04-14Not public
DecisionOutcome2025-04-14Not public
Final order2025-04-14Public
Receipt2025-04-09Not public
Application under r. 9 RoP2025-04-09Not public
Order2025-04-09Not public
Letter to UPC Court of Appeal2025-04-09Not public
Hearing reference2025-04-04Not public
Hearing reference2025-04-04Not public
no oral hearing confirmation2025-04-03Public
Interim-Procedure-Closure2025-04-03Not public
Summon-Oral-Hearing2025-04-03Not public
no oral hearing confirmation2025-04-03Public
Interim-Conference-Decision2025-04-03Not public
Comments2025-03-31Not public
Letter relating to Oral Proceedings2025-03-31Not public
Acknowledgement-of-lodging2025-03-31Not public
Written response2025-03-31Not public
Exhibit BR2a2025-03-31Not public
Exhibit BR22025-03-31Not public
Exhibit BR12025-03-31Not public
Summons2025-03-25Not public
2025.04.25 Letter re availability Novartis(302584925.1).pdf2025-03-25Not public
Comment2025-03-24Not public
Comment2025-03-24Not public
Comment2025-03-24Not public
Comments and request2025-03-22Not public
Summons to oral hearing2025-03-18Not public
Acknowledgement-of-lodging2025-03-14Not public
Panel-Appointment2025-03-14Not public
Receipt2025-03-14Not public
Acknowledgement-of-lodging2025-03-14Not public
Formal-checks_Notification-of-positive-outcome2025-03-14Not public
Acknowledgement-of-lodging2025-03-14Not public
Application2025-03-14Not public
Exhibit TW 2a2025-03-14Not public
Exhibit TW 32025-03-14Not public
Application2025-03-14Not public
Response2025-03-14Not public
Exhibit TW 22025-03-14Not public
Appeal Pleading2025-03-14Not public
Exhibit TW 0 - Payment Court Fees2025-03-14Not public
Order 3 February 20252025-03-14Not public
Formal-checks_Request-for-correction2025-03-13Not public
Acknowledgement-of-lodging2025-03-13Not public
Application2025-03-13Not public
Order 3 February 20252025-03-13Not public
Exhibit TW 32025-03-13Not public
Exhibit TW 0 - Payment Court Fees2025-03-13Not public
Exhibit TW 2a2025-03-13Not public
Exhibit TW 22025-03-13Not public
Appeal Pleading2025-03-13Not public